147 related articles for article (PubMed ID: 24378095)
1. [Correlation between baseline plasma D-dimer levels and prognosis in patients with non-smal cell lung cancer].
Zhang PP; Sun JW; Lu JQ; Ma LL; Li K
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):747-50. PubMed ID: 24378095
[TBL] [Abstract][Full Text] [Related]
2. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
Zhang PP; Sun JW; Wang XY; Liu XM; Li K
Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Zhang C; Jia Y; Jia Y; Zhang X; Li K
Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
[TBL] [Abstract][Full Text] [Related]
4. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
[TBL] [Abstract][Full Text] [Related]
5. The role of plasma D-dimer levels for predicting lymph node and mediastinal lymph node involvement in non-small cell lung cancer.
Gao XL; Wang SS; Cao DB; Liu W
Clin Respir J; 2018 Jun; 12(6):2151-2156. PubMed ID: 29498801
[TBL] [Abstract][Full Text] [Related]
6. Plasma D-dimer value as a predictor of malignant lymph node involvement in operable non-small cell lung cancer.
Chen F; Wang MJ; Li J; Yan CE; Han XH; Wu ZY; Qi J
Tumour Biol; 2015 Dec; 36(12):9201-7. PubMed ID: 26088447
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.
Zhu LR; Li J; Chen P; Jiang Q; Tang XP
Clin Transl Oncol; 2016 Feb; 18(2):178-88. PubMed ID: 26184726
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of preoperative plasma D-dimer level in patients with surgically resected clinical stage I non-small cell lung cancer: a retrospective cohort study.
Kaseda K; Asakura K; Kazama A; Ozawa Y
J Cardiothorac Surg; 2017 Nov; 12(1):102. PubMed ID: 29183325
[TBL] [Abstract][Full Text] [Related]
9. Plasma D-Dimer Level Correlates with Age, Metastasis, Recurrence, Tumor-Node-Metastasis Classification (TNM), and Treatment of Non-Small-Cell Lung Cancer (NSCLC) Patients.
Guo J; Gao Y; Gong Z; Dong P; Mao Y; Li F; Rong J; Zhang J; Zhou Y; Feng H; Guo H; Gu L; An M; Wen K; Zhang J
Biomed Res Int; 2021; 2021():9623571. PubMed ID: 34712737
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.
Betticher DC; Hsu Schmitz SF; Tötsch M; Hansen E; Joss C; von Briel C; Schmid RA; Pless M; Habicht J; Roth AD; Spiliopoulos A; Stahel R; Weder W; Stupp R; Egli F; Furrer M; Honegger H; Wernli M; Cerny T; Ris HB
J Clin Oncol; 2003 May; 21(9):1752-9. PubMed ID: 12721251
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
Liu JW; Li J; Lin G; Shang XQ
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between Plasma D-dimer Count and Features of
Non-small Cell Lung Cancer].
Song X; Wang F; Shen H; Li J; Hu T; Yang Z; Zhou Y; Shi Q
Zhongguo Fei Ai Za Zhi; 2019 Mar; 22(3):151-156. PubMed ID: 30909994
[TBL] [Abstract][Full Text] [Related]
14. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
[TBL] [Abstract][Full Text] [Related]
15. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
[TBL] [Abstract][Full Text] [Related]
16. Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer.
Jiang HG; Li J; Shi SB; Chen P; Ge LP; Jiang Q; Tang XP
Med Oncol; 2014 Jul; 31(7):22. PubMed ID: 24861920
[TBL] [Abstract][Full Text] [Related]
17. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy.
Ge LP; Li J; Bao QL; Chen P; Jiang Q; Zhu LR
Clin Transl Oncol; 2015 Jan; 17(1):57-64. PubMed ID: 24997087
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer.
Antoniou D; Pavlakou G; Stathopoulos GP; Karydis I; Chondrou E; Papageorgiou C; Dariotaki F; Chaimala D; Veslemes M
Lung Cancer; 2006 Aug; 53(2):205-10. PubMed ID: 16769149
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study.
Hou C; Jiang F; Ma H; Zhu Q; Wang Z; Zhao B; Xue T; Tan S; Yang R; Qian Y; Luo X; Zhao M; Xu X; Chen L; Li J
Thorac Cancer; 2019 Feb; 10(2):304-311. PubMed ID: 30609303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
